Free Trial

InMode (INMD) Competitors

InMode logo
$14.91 -0.49 (-3.18%)
As of 04:00 PM Eastern

INMD vs. IRTC, SLNO, PRCT, TMDX, NVST, LIVN, LMAT, ENOV, NVCR, and CNMD

Should you be buying InMode stock or one of its competitors? The main competitors of InMode include iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), LeMaitre Vascular (LMAT), Enovis (ENOV), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.

InMode vs.

iRhythm Technologies (NASDAQ:IRTC) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

InMode has a net margin of 45.91% compared to iRhythm Technologies' net margin of -19.14%. InMode's return on equity of 18.25% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-19.14% -118.83% -11.34%
InMode 45.91%18.25%16.33%

In the previous week, InMode had 10 more articles in the media than iRhythm Technologies. MarketBeat recorded 16 mentions for InMode and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.05 beat InMode's score of 0.79 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
InMode
7 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

InMode has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$591.84M5.30-$123.41M-$3.64-27.43
InMode$394.82M2.63$181.27M$2.356.34

iRhythm Technologies currently has a consensus target price of $119.73, suggesting a potential upside of 19.92%. InMode has a consensus target price of $21.25, suggesting a potential upside of 42.52%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.82
InMode
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

iRhythm Technologies has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Comparatively, InMode has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500.

iRhythm Technologies received 247 more outperform votes than InMode when rated by MarketBeat users. However, 72.97% of users gave InMode an outperform vote while only 66.07% of users gave iRhythm Technologies an outperform vote.

CompanyUnderperformOutperform
iRhythm TechnologiesOutperform Votes
409
66.07%
Underperform Votes
210
33.93%
InModeOutperform Votes
162
72.97%
Underperform Votes
60
27.03%

68.0% of InMode shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

InMode beats iRhythm Technologies on 12 of the 18 factors compared between the two stocks.

Remove Ads
Get InMode News Delivered to You Automatically

Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INMD vs. The Competition

MetricInModeElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.04B$3.08B$5.27B$7.29B
Dividend YieldN/A1.80%5.11%4.32%
P/E Ratio6.3414.5521.6417.60
Price / Sales2.6343.42370.8091.75
Price / Cash10.4044.0938.1534.64
Price / Book1.473.256.353.91
Net Income$181.27M$94.03M$3.20B$247.45M
7 Day Performance-3.56%-4.22%1.34%0.02%
1 Month Performance-18.57%-10.14%-9.78%-7.53%
1 Year Performance-15.38%-22.83%9.22%-0.82%

InMode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INMD
InMode
2.235 of 5 stars
$14.91
-3.2%
$21.25
+42.5%
-12.9%$1.04B$394.82M6.34480Analyst Forecast
News Coverage
IRTC
iRhythm Technologies
0.9182 of 5 stars
$103.20
+1.1%
$119.73
+16.0%
-8.0%$3.24B$591.84M-28.351,790Positive News
SLNO
Soleno Therapeutics
4.7799 of 5 stars
$70.00
+4.1%
$99.63
+42.3%
+82.4%$3.21BN/A-21.0830Analyst Forecast
Positive News
PRCT
PROCEPT BioRobotics
2.3921 of 5 stars
$53.76
+3.2%
$91.43
+70.1%
+4.6%$2.95B$224.50M-27.57430Positive News
TMDX
TransMedics Group
2.751 of 5 stars
$86.84
+7.8%
$122.70
+41.3%
-5.1%$2.92B$441.54M92.38210
NVST
Envista
4.3739 of 5 stars
$15.63
+1.1%
$20.18
+29.1%
-21.0%$2.69B$2.51B-2.4112,700Analyst Forecast
Analyst Revision
News Coverage
LIVN
LivaNova
3.5606 of 5 stars
$35.46
+4.4%
$61.17
+72.5%
-34.8%$1.93B$1.25B84.432,900Positive News
LMAT
LeMaitre Vascular
3.0966 of 5 stars
$83.78
+1.2%
$95.25
+13.7%
+31.3%$1.89B$219.86M45.78490Positive News
ENOV
Enovis
2.2083 of 5 stars
$32.28
+0.8%
$58.50
+81.2%
-44.7%$1.84B$2.11B-14.746,800
NVCR
NovoCure
3.3424 of 5 stars
$16.55
+0.3%
$34.50
+108.5%
+29.4%$1.82B$605.22M-11.821,320Analyst Forecast
News Coverage
Gap Up
CNMD
CONMED
4.6474 of 5 stars
$50.91
-1.6%
$77.20
+51.6%
-35.5%$1.57B$1.31B12.014,100
Remove Ads

Related Companies and Tools


This page (NASDAQ:INMD) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners